207 related articles for article (PubMed ID: 26476899)
21. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
22. Successful use of a modified Goeckerman regimen in the treatment of chronic severe atopic dermatitis: A prospective pilot study.
Farahnik B; Beroukhim K; Danesh M; Nakamura M; Abrouk M; Zhu TH; Singh R; Lee K; Bhutani T; Koo J
J Am Acad Dermatol; 2016 Nov; 75(5):1068-1071. PubMed ID: 27745637
[No Abstract] [Full Text] [Related]
23. Oxidative damage to nucleic acids and benzo(a)pyrene-7,8-diol-9,10-epoxide-DNA adducts and chromosomal aberration in children with psoriasis repeatedly exposed to crude coal tar ointment and UV radiation.
Borska L; Andrys C; Krejsek J; Palicka V; Chmelarova M; Hamakova K; Kremlacek J; Fiala Z
Oxid Med Cell Longev; 2014; 2014():302528. PubMed ID: 25197429
[TBL] [Abstract][Full Text] [Related]
24. Ultraviolet light and tar in the Goeckerman treatment of psoriasis.
Marsico AR; Eaglstein WH; Weinstein GD
Arch Dermatol; 1976 Sep; 112(9):1249-50. PubMed ID: 793524
[TBL] [Abstract][Full Text] [Related]
25. Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis.
de Miguel R; el-Azhary R
Int J Dermatol; 2009 Jun; 48(6):653-8. PubMed ID: 19538381
[No Abstract] [Full Text] [Related]
26. UVABA therapy for psoriasis. Efficacy with shortened treatment times with the combined use of coal tar, anthralin, and metal halide ultraviolet machines.
Swinehart JM; Lowe NJ
J Am Acad Dermatol; 1991 Apr; 24(4):594-7. PubMed ID: 2033137
[TBL] [Abstract][Full Text] [Related]
27. Goeckerman therapy versus biologics in the treatment of psoriasis.
Menter A
J Am Acad Dermatol; 2010 Mar; 62(3):516-7. PubMed ID: 20159322
[No Abstract] [Full Text] [Related]
28. Comparison of once-daily and twice-daily ultraviolet radiation treatments in psoriasis.
Petrozzi JW; de los Reyes O
Arch Dermatol; 1981 Nov; 117(11):695-7. PubMed ID: 7316527
[TBL] [Abstract][Full Text] [Related]
29. Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis.
Taibjee SM; Cheung ST; Laube S; Lanigan SW
Br J Dermatol; 2005 Nov; 153(5):960-6. PubMed ID: 16225606
[TBL] [Abstract][Full Text] [Related]
30. CC and CXC chemokines patterns in psoriasis determined by protein array method were influenced by Goeckerman's therapy.
Pohl D; Andrýs C; Borská L; Fiala Z; Hamáková K; Ettler K; Krejsek J
Acta Medica (Hradec Kralove); 2009; 52(1):9-13. PubMed ID: 19754001
[TBL] [Abstract][Full Text] [Related]
31. LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone.
Bagel J
J Drugs Dermatol; 2009 Apr; 8(4):351-7. PubMed ID: 19363853
[TBL] [Abstract][Full Text] [Related]
32. Genotoxic hazard and cellular stress in pediatric patients treated for psoriasis with the Goeckerman regimen.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Vellappally S; Vimal J; Fiala Z
Pediatr Dermatol; 2009; 26(1):23-7. PubMed ID: 19250400
[TBL] [Abstract][Full Text] [Related]
33. Possible genotoxic risk of combined exposure to pharmaceutical coal tar and UV-B radiation.
Borská L; Fiala Z; Smejkalová J; Hamáková K; Kremlácek J
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S14-5. PubMed ID: 15141964
[TBL] [Abstract][Full Text] [Related]
34. Genotoxic changes in peripheral lymphocytes after therapeutic exposure to crude coal tar and ultraviolet radiation.
Malkova A; Kohlerova R; Fiala Z; Hamakova K; Selke-Krulichova I; Borska L
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):553-558. PubMed ID: 27283756
[TBL] [Abstract][Full Text] [Related]
35. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study.
Pittelkow MR; Perry HO; Muller SA; Maughan WZ; O'Brien PC
Arch Dermatol; 1981 Aug; 117(8):465-8. PubMed ID: 7259240
[TBL] [Abstract][Full Text] [Related]
36. Goeckerman therapy: a very effective, yet often forgotten treatment for severe generalized psoriasis.
Moscaliuc ML; Heller MM; Lee ES; Koo J
J Dermatolog Treat; 2013 Feb; 24(1):34-7. PubMed ID: 22329632
[TBL] [Abstract][Full Text] [Related]
37. Components of the Goeckerman regimen.
Le Vine MJ; White HA; Parrish JA
J Invest Dermatol; 1979 Aug; 73(2):170-3. PubMed ID: 379242
[TBL] [Abstract][Full Text] [Related]
38. Droplet Digital PCR Analysis of GSTM1 Deletion Polymorphism in Psoriatic Subjects Treated with Goeckerman Therapy.
Beránek M; Fiala Z; Kremláček J; Andrýs C; Hamáková K; Palička V; Borská L
Acta Medica (Hradec Kralove); 2016; 59(3):75-78. PubMed ID: 27639151
[TBL] [Abstract][Full Text] [Related]
39. Membrane and soluble Toll-like receptor 2 in patients with psoriasis treated by Goeckerman therapy.
Kondelkova K; Krejsek J; Borska L; Fiala Z; Hamakova K; Ettler K; Andrys C
Int J Dermatol; 2014 Nov; 53(11):e512-7. PubMed ID: 25266302
[TBL] [Abstract][Full Text] [Related]
40. Serum level of a soluble form of endoglin (CD105) is decreased after Goeckerman's therapy of psoriasis.
Pohl D; Andrýs C; Borská L; Fiala Z; Hamaková K; Ettler K; Krejsek J
Acta Medica (Hradec Kralove); 2011; 54(2):59-62. PubMed ID: 21842718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
